Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin

類似資料

• Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway
  著者:: Chen, Ting, 等
  出版事項: (2014)
• Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1
  著者:: Wang, Changyuan, 等
  出版事項: (2016)
• Cilastatin protects against imipenem-induced nephrotoxicity via inhibition of renal organic anion transporters (OATs)
  著者:: Huo, Xiaokui, 等
  出版事項: (2019)
• Organic anion transporters also mediate the drug–drug interaction between imipenem and cilastatin
  著者:: Zhu, Yanna, 等
  出版事項: (2020)
• A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression
  著者:: Wang, Ting, 等
  出版事項: (2021)